Alvotech SDB
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic art… Read more
Market Cap & Net Worth: Alvotech SDB (ALVO-SDB)
Alvotech SDB (ST:ALVO-SDB) has a market capitalization of $28.71K (Skr322.03K) as of March 18, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #12500 globally and #107 in its home market, demonstrating a -8.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alvotech SDB's stock price Skr33.10 by its total outstanding shares 9729 (9.73K).
Alvotech SDB Market Cap History: 2025 to 2026
Alvotech SDB's market capitalization history from 2025 to 2026. Data shows growth from $40.28K to $28.71K (0.00% CAGR).
Alvotech SDB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Alvotech SDB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ALVO-SDB by Market Capitalization
Companies near Alvotech SDB in the global market cap rankings as of March 18, 2026.
Key companies related to Alvotech SDB by market ranking:
- Anhui Huamao Textile Co Ltd (SHE:000850): Ranked #12491 globally with a market cap of $321.50 Million USD ( CN¥2.36 Billion CNY).
- Linkage Software Co Ltd (SHG:688588): Ranked #12492 globally with a market cap of $321.48 Million USD ( CN¥2.36 Billion CNY).
- Anhui Fengyuan Pharmaceutical Co Ltd (SHE:000153): Ranked #12501 globally with a market cap of $320.56 Million USD ( CN¥2.35 Billion CNY).
- Nanjing Huamai Tech Co Ltd (SHG:603042): Ranked #12502 globally with a market cap of $320.52 Million USD ( CN¥2.35 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #12491 | Anhui Huamao Textile Co Ltd | SHE:000850 | $321.50 Million | CN¥5.15 |
| #12492 | Linkage Software Co Ltd | SHG:688588 | $321.48 Million | CN¥12.96 |
| #12501 | Anhui Fengyuan Pharmaceutical Co Ltd | SHE:000153 | $320.56 Million | CN¥6.58 |
| #12502 | Nanjing Huamai Tech Co Ltd | SHG:603042 | $320.52 Million | CN¥20.31 |
Alvotech SDB Historical Marketcap From 2025 to 2026
Between 2025 and today, Alvotech SDB's market cap moved from $40.28K to $ 28.71K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr28.71K | -28.73% |
| 2025 | Skr40.28K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Alvotech SDB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $28.71K USD |
| MoneyControl | $28.71K USD |
| MarketWatch | $28.71K USD |
| marketcap.company | $28.71K USD |
| Reuters | $28.71K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.